Thus, activation of SIRT1 maintains gut barrier function, which is compromised in obesity [125] and through its regulation of gut inflammation controls colitis and colon cancer, which are also more prevalent in obese individuals [126]. Here, SIRT1 is linked to colonic neoplasm.